Immunogens for HIV vaccination

Immunogens for HIV vaccination

Inventors: Christian Brander, Beatriz Mothe, Anuska Llano

The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.

Reference: WO/2013/110818; PCT/EP2013/051596
Priority Date: 27 Jan 2012
Publication date: 1 Aug 2013
Granted: US, AU, China, Israel, Japan, Republic of Korea, Mexico, New Zealand, Russian Federation, South Africa
Pending: Brazil, Hong Kong
Published: Canada, India
Case inactive: EP  
Licensed to: Aelix Therapeutics

Institution: Institut de Recerca de la Sida IrsiCaixa, Institució Catalana de Recerca i Estudis Avançats (ICREA)
IrsiCaixa inventors: Christian Brander, Beatriz Mothe, Anuska Llano

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut


HR Excellence in Research

Member of:


In cooperation with: